The FDA plans to approve selected high-priority drug application submissions in 1 to 2 months rather than 10 to 12.

Automated data review assists in identifying problematic opioid usage, outperforming manual methods in sensitivity and positive predictive value.

Mortality rates associated with calciphylaxis are lower than previously observed, with rates of 28.88% at 1-year and 29.92% at 2-years.

The incidence and prevalence of CTD-ILD in the US is most common among women and older individuals, affecting approximately ...

The leading causes of readmission among patients who received THA included sepsis (14.6%), nonseptic infections (14.8%), ...

Research on the preferences of patients with AD, caregivers, and health care providers may be influenced by pharmaceutical company sponsorship.

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...

The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.

The intensity of CKD-aP is linked to levels of systemic inflammation, with reductions in these levels seen with difelikefalin treatment.

Early childhood atopic dermatitis does not affect executive function during middle childhood, particularly in those with mild phenotypes.

The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

Patients who received oral tranexamic acid 500 mg daily for 3 months had reduced melasma severity and systemic inflammation markers.